{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:11Z","timestamp":1786118651356,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2,19]]},"DOI":"10.1097\/qad.0b013e32802f7d7c","type":"journal-article","created":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T04:05:02Z","timestamp":1171253102000},"page":"521-524","source":"Crossref","is-referenced-by-count":4,"title":["Durable neutralizing antibodies after remote smallpox vaccination among adults with and without HIV infection"],"prefix":"10.1097","volume":"21","author":[{"given":"Virginia L","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210130","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group. Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"key":"R2-17-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/infdis\/125.2.161","article-title":"Smallpox in Europe, 1950\u20131971","volume":"125","author":"Mack","year":"1972","journal-title":"J Infect Dis"},{"key":"R3-17-20210130","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammerlund","year":"2003","journal-title":"Nat Med"},{"key":"R4-17-20210130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1086\/368093","article-title":"Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome","volume":"36","author":"Bartlett","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"RR-7","key":"R5-17-20210130","first-page":"1","article-title":"Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)","volume":"52","author":"Wharton","year":"2003","journal-title":"MMWR Recomm Rep"},{"key":"R7-17-20210130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/376557","article-title":"Development of a novel vaccinia neutralization assay based on reporter gene expression","volume":"188","author":"Manischewitz","year":"2003","journal-title":"J Infect Dis"},{"key":"R8-17-20210130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against lethal monkeypox challenge","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"key":"R9-17-20210130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.125.1.221","article-title":"The response of human lymphocyte subpopulations to measles, mumps, and vaccinia viral antigens","volume":"125","author":"McFarland","year":"1980","journal-title":"J Immunol"},{"issue":"Suppl. 1","key":"R10-17-20210130","first-page":"S123","article-title":"Persistence of vaccine-induced antibody to measles 26-33 years after vaccination","volume":"189","author":"Dine","year":"2004","journal-title":"J Infect Dis"},{"key":"R11-17-20210130","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/0264-410X(94)90247-X","article-title":"Measles seroprevalence and vaccine response in HIV-infected adults","volume":"12","author":"Wallace","year":"1994","journal-title":"Vaccine"},{"key":"R12-17-20210130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/CDLI.12.4.520-524.2005","article-title":"Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations","volume":"12","author":"Hatakeyama","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"R13-17-20210130","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.4049\/jimmunol.171.10.4969","article-title":"Cutting edge: long-term B cell memory in humans after smallpox vaccination","volume":"171","author":"Crotty","year":"2003","journal-title":"J Immunol"},{"key":"R14-17-20210130","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1128\/JVI.78.8.3811-3816.2004","article-title":"Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells","volume":"78","author":"Amara","year":"2004","journal-title":"J Virol"},{"key":"R15-17-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"key":"R16-17-20210130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.20011626","article-title":"Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population","volume":"195","author":"O'Connor","year":"2002","journal-title":"J Exp Med"},{"key":"R17-17-20210130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1","article-title":"Plasma cells for a lifetime?","volume":"32","author":"Manz","year":"2002","journal-title":"Eur J Immunol"},{"key":"R18-17-20210130","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1126\/science.1076071","article-title":"Maintenance of serological memory by polyclonal activation of human memory B cells","volume":"298","author":"Bernasconi","year":"2002","journal-title":"Science"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e32802f7d7c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:22:19Z","timestamp":1786033339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200702190-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,19]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32802f7d7c","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2,19]]}}}